You have 9 free searches left this month | for more free features.

City

Copenhagen (1)

Houston (1)

Madison (1)

Condition

Neuroendocrine Tumors (3)

GEP-NET (1)

Neuroendocrine Carcinoma (1)

Neuroendocrine Carcinoma Metastatic (1)

Somatostatin Receptor-positive Neuroendocrine Tumor (1)

Overall Status

Completed (1)

Enrolling by invitation (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

phase 3 (1)

Sponsor

Radiomedix, Inc. (1)

Rigshospitalet, Denmark (1)

University of Wisconsin, Madison (1)

Collaborator

Intervention

64cu-dotatate (3)

177lu-dotatate (1)

18f-fdg (1)

photon emission tomography / ct (pet/ct) (1)

single photon emission computed tomography/ computed tomography (spect/ct) (1)

Study Documents

Intervention Type

drug (3)

device (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

64cu-dotatate

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

Enrolling by invitation

GEP-NET
+3 more

18F-FDG
64Cu-Dotatate

Copenhagen, Denmark

Rigshospitalet

Jan 24, 2023

Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor Trial in Madison (Single Photon Emission Computed

Not yet recruiting

Neuroendocrine Tumors
Somatostatin Receptor-positive Neuroendocrine Tumor

Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
+3 more

Madison, Wisconsin

University of Wisconsin - Madison

Nov 2, 2023

Neuroendocrine Tumors Trial in Houston (64Cu-DOTATATE)

Completed

Neuroendocrine Tumors

64Cu-DOTATATE

Houston, Texas

Excel Diagnostics and Nuclear Oncology Center

Jul 19, 2019